Your browser doesn't support javascript.
loading
PROPROTEIN CONVERTASE 1/3 DEFICIENCY WITH PELVIC EWING SARCOMA.
Oral, H; Guven, D C; Özdemir, D Ates; Usubütün, A; Gonc, N; Arik, Z.
Afiliación
  • Oral H; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Guven DC; Department of Internal Medicine, Division of Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Özdemir DA; Department of Pathology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Usubütün A; Department of Pathology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Gonc N; Department of Pediatrics, Division of Pediatric Endocrinology, University Faculty of Medicine, Ankara, Turkey.
  • Arik Z; Department of Internal Medicine, Division of Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Acta Endocrinol (Buchar) ; 18(4): 508-511, 2022.
Article en En | MEDLINE | ID: mdl-37152885
ABSTRACT
Proprotein convertase 1/3 (PC 1/3) deficiency is a rare, autosomal recessive disorder caused by mutations in the PCSK1 gene. The disease is characterized by early-onset chronic diarrhea/malabsorption, followed by severe obesity and hormonal deficiencies such as hypocortisolism, hypothyroidism, diabetes insipidus, hypogonadism, growth deficiency, and diabetes mellitus. Ewing's sarcoma is a rare tumor, usually of small dimensions of neuroectodermal origin that is difficult to distinguish pathologically from a primitive neuroectodermal tumor. A 22-year-old female patient with PC 1/3 deficiency was admitted to our clinic with recurrent urinary tract infections. Magnetic resonance imaging (MRI) revealed an 11x12 cm pelvic mass displacing the uterus. A core-needle biopsy was performed on the pelvic mass. As a result of the pathological evaluation, it was diagnosed with pelvic Ewing's sarcoma. The patient was started on the VAC-IE chemotherapy protocol. We report a case of pelvic Ewing's sarcoma in a patient with PC 1/3 deficiency. Further research is needed to assess malignancy risk in metabolic disorders including very rare disorders like PC 1/3 deficiency.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Acta Endocrinol (Buchar) Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Acta Endocrinol (Buchar) Año: 2022 Tipo del documento: Article País de afiliación: Turquía
...